Sponsored Content
News|Articles|December 13, 2023
DEVELOPICK™: High-throughput developability assessment to enable efficient formulation development
Author(s)Samsung Biologics
Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond
Related Content
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Hold Times in Biopharmaceuticals
2
Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
5